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SUSTAINED ADRENERGIC SIGNALING PROMOTES CERVICAL CANCER
TUMOR PROGRESSION
Nouara C. Sadaoui, B.A.
Advisory Professor: Anil K. Sood, M.D.
Background: Chronic stress and sustained adrenergic signaling are known to
promote tumor progression. The underlying mechanisms behind this process are
not well understood. We examined the effects of sustained adrenergic signaling
on cervical cancer progression through increased expression of HPV oncogenes,
E6 and E7.
Materials and Methods: ADRβ expression levels were examined in patientderived cervical cancer samples. We used an orthotopic model of cervical cancer
to investigate the effects of restraint stress on tumor growth and metastasis. We
evaluated the in vivo effects of a β-blocker, propranolol, and HPV E6/E7 siRNA.
In vitro, ADRβ positive cervical cancer cell were treated with norepinephrine (NE)
or isoproterenol (ISO) to examine intracellular responses. Invasion and anoikis
assays were performed to elucidate the biological effect of NE. Furthermore, the
significance of secreted HPV was examined.
Results: Among tumor samples evaluated from cervical cancer patients, 61%
had increased ADRβ2 expression, which correlates with decreased overall
survival (p=0.038). In an orthotopic model of cervical cancer, chronic stress led to
increased tumor weight and nodules. This effect was abrogated with propranolol.
Further, treatment with HPV E6/E7 siRNA in the restraint stress model
decreased tumor growth and metastases. In vitro, HPV E6/E7 mRNA was
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elevated in cell lysates and corresponding supernatant after treatment with NE or
ISO. NE exposure resulted in increased invasion and migration of SiHa cells,
while E6/E7 siRNA abrogated these effects. After NE exposure, ME-180 cells
showed a 45% reduction in anoikis compared to controls. Fibroblasts cultured
with supernatant from SiHa cells had increased migration and elevated mRNA of
pro-inflammatory genes CXCL2 and IL-8. Further, the fibroblasts took up cervical
cancer cell derived exosomes that contain HPV E7. The conditioned fibroblasts
demonstrated the ability to increase cervical cancer cell invasion when cocultured.
Conclusion: This study shows increased adrenergic signaling promotes cervical
cancer growth and progression. Disruption of this pathway with β-blockers could
provide a novel complement to current therapies. In addition, we show HPV
oncogenes E6 and E7 can be influenced by catecholamines. We also show
exosomes as a potential mean of communication between cervical cancer cells
and fibroblasts in vitro. The functional implications of this study need to be
explored further.
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Background and Introduction
Cervical cancer
There are an estimated 12,000 new cases of cervical cancer in the US
each year and about a third of the women affected die because of the
disease. Globally, the disease causes around a 250,000 deaths a year [1].
The primary cause of cervical cancer is human papillomavirus (HPV);
additional contributors include cigarette smoking, multiple sex partners, and
immunosuppression [2]. The death rate from cervical cancer in developed
countries has declined about 70% in the past 50 years because of increased
use of the Papanicolaou (Pap) test [3]. The Pap test is performed by
collecting cells from the outer opening of the cervix, which are then analyzed
for abnormalities in aims of detecting early pre-cancerous lesions and
cancer.
In early stages of the disease, conization or hysterectomy is used to
remove cancerous lesions. Radiation and chemotherapy may be used for
disease with regionalized spread [4]. Advanced cervical cancer can spread
into the vagina and uterus, growing onto the muscular wall of the pelvis, and
even can block one or both ureters, bladder, or rectum. The cancer can also
metastasize to distant organs such as the liver and lungs. Larger early stage
tumors typically require radical hysterectomy, including removal of local
lymph nodes [5]. Palliative care is important in order to improve quality of life
and relieve symptoms from treatment.
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Human papillomavirus (HPV)
The primary cause of cervical cancer is the HPV. There are over 100
different strains of HPV; among these there are low risk types (6 and 11)
which are most commonly associated with warts, and the high-risk types
(HPV16, 18, 31, 33,45, 52, and 58) which are associated with cancer [6] [7].
High risk-HPV (HR-HPV) types 16 and 18 account for 70% of the HPV
positive cervical cancer tumors [8]. The virus first infects the basal layer of
the epithelium, typically entry is through an abrasion that exposes the basal
cells [7]. The capability of the virus to directly infect stromal cells has not
been previously described nor accepted in the virology field, HPV only infects
basal cells of the skin and mucosa [9]. During the establishment of infection,
the virus associates with heparan sulphate proteoglycans (HSPG) on the cell
surface prior to being internalized [10]. The cell and virus replicate together
in the proliferative layers of the epithelium. In the top layers of the epithelium,
the virus is fully packaged and expression of all the viral proteins is high. The
encapsidated virus can exit the cell as infectious virus particles at this point.
Conversely, the virus can remain in a latent phase, in which viral replication
has ceased [11]. In latency, viral gene expression is minimal and the virus is
maintained episomally or integrated in host DNA. Persistent infection with
HPV and additional aberrations in the cell ultimately lead to the tumor growth
[12].
The virus is a small double stranded DNA virus (Figure 2). The genome
has an upper regulatory region (URR), 6 early open reading frames (ORF)
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(E1, E2, E4, E5, E6, E7), and 2 late ORFs (L1 and L2) [13]. After the host cell
is infected early genes E1 and E2 are expressed which play roles in
transcription and replication of the virus [14]. The E2 protein binds specific
regions in the URR to negatively regulate the E6/E7 promoter. E6 and E7, the
oncogenes of the virus, are transcribed bi-cistronically [15].The URR also
contains other transcription factor binding sites that have been shown to
modulate the promoter function as well, such as AP1, Oct-1, SP1, and
glucocorticoid response elements [16]. The two late genes L1 and L2 encode
the capsid protein coat of the virus [17].

Figure 1. Illustration of HPV in the cell. The HR-HPV episome contains all
8 genes and an URR, typically spanning 8,000bp. The most common
integrated form of HPV contains an undisrupted URR, E6 and E7. Loss of E2
inhibitory effects plus stable expression of the oncogenes results in cellular
immortality, increased proliferation, and genomic instability[12].
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HPV oncogenes: E6 and E7
The E6 protein has many known interactions and functions in the cell. The
most canonical oncogenic function is the ability to inactivate p53-dependent
growth arrest and apoptosis [18]. Additional functions include the degradation
of pro-apoptotic proteins BAX and BAK [19], and to promote immortalization
E6 has a known role in up regulating the transcription of hTERT [20].
E7 proteins associate with the retinoblastoma protein to induce hyper
proliferation. This interaction allows E2F6 mediated cell cycle progression
through the S-phase, which for viral genome replication is favorable [21]. E7
has also been shown to deregulate the cell cycle by directly interacting with
p21 and p27 [22].

Stress and cancer
Studies have shown a strong relationship between psychosocial factors,
including depression, low social support, and hopelessness, and cancer
progression [23]. Cervical cancer patients typically present with greater
disruptions in quality of life (QOL) than in other cancers; factors that
contribute to their psychosocial distress include poor coping skills,
depression, anxiety, social isolation, and drug use [23]. Unfortunately, cervical
cancer patients without social and clinical support service and the lack of
access to care, often face a delay in diagnosis and have advanced disease at
presentation [24]. For cervical cancer specifically, in one study patients were
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given a stressful life events (SLE) assessment as a measure of psychosocial
distress and those with higher scores were associated with higher risk for
squamous intraepithelial lesions (SIL) [25]. In another study, women with
negative coping styles were also more likely to have SIL when compared to
those with positive coping styles [26]. High levels of pessimism, despair,
anxiety, and uncontrollable stressors are all associated with higher risk for SIL
[27]. Studies to date are correlative and future investigation of the
mechanisms behind this relationship need to be explored.

Figure 2. The stress response. In response to a stimulus both the
hypothalamic-pituitary-adrenal axis (HPA) and sympathetic nervous system
(SNS) are activated to adapt physiologically to a threat. Through the HPA axis
the hypothalamus secretes corticotrophin releasing factor (CRF) and arginine
vasopressin (AVP), which activate the pituitary to produce hormones such as
adrenocorticotropic hormone (ACTH). Circulating ACTH stimulates production
of glucocorticoids. Additionally, when sympathetic nerves of the SNS are
activated, they can also result in the release of epinephrine and
norepinephrine.
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Activation of the SNS or HPA prepares an individual to survive a threat
and the physiological stress responses are considered adaptive (Figure 2)
[28]. The acute stress response is commonly known as the “fight or flight”
response and has a clear onset and offset with transient changes in
hormones. However, under chronic stress the physiological systems are
negatively affected by persistent elevation of stress hormone levels [29].
Studies of behavioral stress in animals have provided reliable models for
dissecting stress effects on tumor progression [30]. Restraint stress, swim
stress, social confrontation or isolation are models commonly used for
inducing

experimental

stress

[30].

These

models

accurately

mimic

physiological stress pathway activation which disrupts homeostasis as seen
in patients [31]. Previous studies in vivo suggest chronic stress plays a role in
tumor growth and metastasis. In an orthotopic murine model of breast cancer,
chronic stress increased lung metastases significantly [32]. In another study,
restraint stress led to increased production of vascular endothelial growth
factor (VEGF), and enhanced angiogenesis and tumor burden in an
orthotopic murine model of ovarian cancer [33]. In vitro effects of stress
hormones parallel the results seen in animal models. Catecholamine
exposure led to increased expression of metalloproteinase (MMP) 2 and 9,
which increased ovarian cancer cell invasion compared to control [34].
Furthermore, ovarian cancer cells exposed to NE induced FAK-mediated
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resistance to anoikis [35]. Adrenergic stimulation also has been shown to
play a role in suppressing NK cell activity [36].
β-adrenergic signaling is the primary mediator of the SNS induced
responses involved in the promotion of cancer [37]. Because this signaling
pathway has shown to be critical in tumor progression, β antagonist/blockers
provide an appealing adjuvant therapy strategy for abrogating the impact of
stress.

Studies done in patients with prostate, lung, ovarian, and breast

cancers have shown higher survival and lower recurrence and metastasis
rates when taking a β-blocker [38]. Current studies have not addressed βblockers use in cervical cancer patients however; many clinical based
assessments have supported the use of β-blockers in patient interventions
[39].
Although the effects of stress and cancer are established, the role of
stress in viral oncology is not well studied [40]. HPA or SNS can directly
affect; viral replication, and activation of viral oncogenes, or indirectly biobehavioral

factors

can

cause

evasion

of

immune

response

[41].

Neuroendocrine function has been shown to modulate tumor associated
viruses such as; Hepatitis B and C virus, Kaposi’s sarcoma-associated
herpes virus (KSHV), Human immunodeficiency virus 1 (HIV1), and Epstein–
Barr virus (EBV). Under chronic stress reactivation and increased expression
of EBV and Hepatitis B and C viruses has been reported [42] [43]. βadrenergic signaling induces a viral transcription factor in KSHV via a
cAMP/PKA signaling pathway directly promoting lytic replication of the virus
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[44]. Additionally, in cells infected with HIV1, replication was accelerated in
response to norepinephrine through a PKA-dependent mechanism [45]. To
our knowledge no relationship between catecholamine’s and HPV has been
shown.

Fibroblasts in the tumor microenvironment
Fibroblasts are a non-epithelial cell type in connective tissue primarily
responsible for depositing extracellular matrix. Fibroblasts are often referred
to as a scaffolding cell type, which have a well-studied role in wound healing
[46], regulation of epithelial cell differentiation [47], and regulation of
inflammation [48]. An activated fibroblast is referred to as a myofibroblast
and this is associated with the type found in wound healing and more recently
tumors [49]. The fibroblast associated with cancer cells and the tumor stroma
are known as carcinoma-associated fibroblasts (CAFs) [50]. Studies of
fibroblasts in the tumor microenvironment compared to normal fibroblasts
have shown increases in migration, increases in pro-inflammatory genes, and
increased growth factor secretion [51]. CAFs can be distinguished from
normal fibroblast by their expression of fibroblast activating protein (FAP) [52]
and increases in alpha-smooth muscle actin (α-SMA) protein [53]. How CAFs
might contribute to the promotion of cancer is currently a very broad and
popular topic of interest.

Exosomes
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For intercellular communication, cells can release vesicles known as
exosomes. Exosomes origin is from endosomes and their size ranges from
30-120 nm [54]. The most common pathways used for exosomal release are
dependent upon SMPD2, Rab family proteins (Rab11,27,35), and ESCRT
machinery proteins[55]. These vesicles can transfer biological information,
such as membrane receptors, mRNAs, RNA, DNA, or proteins, between cells
[56]. Exosomes content and proposed function can be different depending on
the type of cell that release them (epithelial cells, macrophages, platelets)
[57].

Extracellular vesicles content and specifically how to target these

pathways in cancer are being studied extensively [55, 58].
Recent studies have shown tumor-associated viruses (HSV, HIV, and
EBV) have release and uptake mechanisms similar to exosomes [59].
Further, virus containing cells can infect surrounding cells via microvesicles
[60] [61]. Extracellular vesicles also provide a way for the viruses to evade
and alter immune system to prevent their own destruction [62]. The
understanding of the precise mechanism of communication between viral
infected cells and their microenvironment paves new directions for viral
oncology.
The impact of neuroendocrine modulation on HPV in cervical cancer cells
and the biological consequences are the focus of this thesis. The possibility
that cervical cancer derived exosomes could carry HPV oncogenes prompted
us to specifically consider their role in manipulating the microenvironment to
help promote cervical cancer progression.
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Hypotheses and Specific Aims
The overall hypotheses of this project are:
1) Daily restraint stress promotes tumor growth in an orthotopic model of
cervical cancer
2) Adrenergic activation will result in increased levels of HPV oncogenes E6
and E7 in cervical cancer cells
3) Secreted HPV can be transferred via exosomes to other stromal populations
in the microenvironment which facilitates the invasion of cervical cancer cells

These hypotheses can be unified into a central hypothesis, which is modeled
in Figure 3. HPV positive cervical cancer cells respond to catecholamines by
increasing the oncogene’s mRNA and protein levels. The three biological
consequences of the sustained adrenergic signaling include 1) increased
invasion and migration of cancer cells, 2) resistance to anoikis (in both cases
an E6/E7- dependent mechanism is suspected), and 3) the virus is packaged
and secreted via exosomes. Following the transfer of HPV to stromal
populations, the fibroblast cells are altered for establishing more permissive
conditions for tumor growth and metastasis. The following specific aims will
test the hypotheses highlighted in this project:
Specific Aim 1: To determine the biological effect of chronic stress on cervical
cancer growth and progression using orthotopic mouse models.
Specific Aim 2: To determine the functional consequences of catecholaminemediated increases in HPV oncogenes E6 and E7 in cervical cancer cells.
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Specific Aim 3: To evaluate the role of exosomal HPV oncogenes in cell-tocell communication in the tumor microenvironment.

Figure 3. Central Hypothesis. HPV positive cervical cancer cells respond to
stress hormones by increasing HPV oncogene expression. Biological
consequences of stress in cervical cancer cells include increased invasion
and migration and resistance to anoikis. The cervical cancer cells can secrete
HPV in exosomes, which modulate the tumor microenvironment by being
uptake by cell types such as, fibroblast. Increases in pro-inflammatory genes
expression and increased proliferation and migration of fibroblasts promote a
permissive environment for tumor progression of cervical cancer.
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Methods
Cell lines and tissue culture
SiHa and CaSki cells were maintained in RPMI supplemented with 15%
fetal bovine serum, and 0.1% gentamicin sulfate (Gemini Bioproducts,
Calabasas, CA). ME-180 was maintained in McCoy's 5a Medium Modified with
10% fetal bovine serum, and 0.1% gentamicin sulfate. C4-1 cell line was
maintained in Waymouth's MB 752/1 medium with 10% fetal bovine serum, and
0.1% gentamicin sulfate. The C33A cell line was cultured in Eagle's Minimum
Essential Medium supplemented with 10% fetal bovine serum, and 0.1%
gentamicin sulfate. The telomerase-immortalized human normal ovarian
fibroblast (NOF) line NOF151-hTERTwere maintained in

MCDB 105/199

medium (1:1) supplemented with 10% fetal bovine serum, 0.01% epidermal
growth factor, and 0.01% Penicillin Streptomycin. All experiments were
performed at 70-85% confluence and cell lines were routinely screened for
mycoplasma.
Table 1. Cervical cancer cell lines and HPV status
Cervical cancer cell line
HPV status
SiHa
Positive, HPV 16
CaSki
Positive, HPV 16
ME-180
Positive, HPV 18
C4-1
Positive, HPV 18
C33A
Negative
Animal studies
All animal work was done in accordance with protocols approved by the
MD Anderson Institutional Animal Care and Use Committee.
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involving human cells lines were performed in 8-12 weeks-old female athymic
nude obtained from Taconic Farms (Hudson, NY). All animals were cared for in
the accordance to the guidelines set forth by the American Association for
Accreditation of Laboratory Animal Care and the US Public Health Service policy
on Human Care and Use.

In vivo model of cervical cancer and tissue processing
For all animal experiments, cells were harvested using trypsin-EDTA,
neutralized with FBS-containing media, washed, and re-suspended to the
appropriate cell number in HBSS prior to injection. SiHa and ME-180 cells
(1x106) cells were transduced with lentivirus-encoding luciferase and expanded
for injection. Nude mice were anesthetized using a ketamine-‐‑based anesthesia
(100 mg/kg ketamine, 2.5 mg/kg xylazine, 2.5 mg/kg acepromazine) prior to
surgery. After complete anesthesia, a small incision was made in the lower
abdomen and the uterus was exposed where we then injected cells onto the top
of the cervix where it meets the lower uterine segment. Mice were anesthetized
with isoflourane and imaged once weekly for luminescent signals using Xenogen
IVIS system. Tissue specimens used for all analyses were fixed in either optimal
cutting temperature compound (OCT) (Miles, Elkhart, IN), formalin, or snap
frozen in liquid nitrogen. Blood was collected immediately before necropsy,
serum was allowed to clot for 20 minutes at room temperature. Samples were
then centrifuged for 30 minutes at 2500 RPM. Supernatant was collected and
stored at -80°C.
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Restraint Stress Model
To experimentally induce stress, we use a daily restraint-stress procedure
in which the animals are enclosed in a movement-restricted space for 2 hours
daily for 21 days. Animals were given 7 days after laparotomy surgery to recover
before restraint stress started. The nude mice were randomized (10 mice per
treatment) into four groups: 1) control no stress, 2) control restraint stress, 3)
propranolol no stress, and 4) propranolol restraint stress. All mice received daily
intraperitoneal injection of PBS or propranolol, 2mg/kg. Animals were
subsequently sacrificed seven days after stress was ceased. Researchers
blinded to the groups noted distribution, mouse weight, tumor weight, and the
number of nodules. The same model system was used for the E6/E7 siRNA
experiment.

SiRNA preparation and treatment
HPV16

E6/E7

(GUCGAUGUAUGUCUUGUUGCAGAUC)

and

non-

targeting control (UUCUCCGAACGUGUCACGU) sequence specific siRNA was
obtained from Sigma Aldrich (Woodlands, TX). For in vitro studies, Lipofectamine
2000 transfection reagent (Invitrogen, Carlsbad, CA) was used according to
manufacturer protocol to transiently transfect cells. For in vivo studies, siRNA
was incorporated into 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC)
nanoliposomes. For each treatment, 3.5 µg of siRNA was reconstituted in 200µl
of sterile phosphate-buffered saline (PBS) and administered by intraperitoneal
injection biweekly.
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Quantitative real-time PCR
Total RNA from either tumor tissue or cell lines was extracted using
Qiagen RNeasy Kit (Qiagen, Valencia, CA). Free-circulating RNA from serum or
conditioned media was isolated using QIAamp Circulating Nucleic Acid Kit
(Qiagen, Valencia, CA). cDNA was generated using 1µg of the RNA using Verso
cDNA kit (Thermo Scientific, Houston, TX) per the manufacturer’s instructions.
cDNA was subjected to amplification via real-time PCR using specific primer
sequences (100ng/µl) which are specified in Table 1. Quantitative values were
obtained for each sample that was normalized to its 18S content.

Conventional PCR
DNA was extracted from serum, conditioned media, or exosomes using
QIAamp MiniElute Virus Spin Kit (Qiagen, Valencia, CA). 1 µl of extracted total
DNA or cDNA was used as template. All PCRs were performed in a final volume
of 25 µl under identical conditions on an Applied BioSystems 9500. PCR
amplification was performed with 1µl of each primer (100ng/µl), 12 µl of PCR
Master Mix (Promega, Madison, WI) and 9.5 µl dH2O. The PCR mixture was
subjected to 30 cycles of amplification consisting of denaturation at 94°C for 1
min, annealing at 54°C for 45 s, and elongation at 72°C for 1 min. The first cycle
was preceded by 3 min of denaturation at 94°C and the last cycle was followed
by 10 min incubation at 72°C. The integrity of extracted mRNA was tested by
amplification

of

Beta-Actin.

Amplification

products

were

analyzed

by

electrophoresis on 2-5% agarose gels and stained with Ethidium Bromide.
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Table 2.PCR primer sequences.
Gene
Forward Sequence
HPV16 AAGCAACAGTTACTGCGACGTG
E6/E7
HPV
AATGTTTCAGGACCCTACGG
16 E6
HPV
TTTGCAACCAGAGACAACTGA
16 E7
HPV
CGGAAATCCAGTGTATGAGC
16 E2
HPV16 TTATTGCTGATGCAGGTGAC
L1
HPV
GCATGGACCTAAGGCAACAT
18 E7
PTGS2 CCCTTGGGTGTCAAAGGTAA
VEGF
AGCTGCGCTGATAGACATCC
IL6
GTCAGGGGTGGTTATTGCAT
IL8
AGCACTCCTTGGCAAAACTG
CXCL2 GCTTCCTCCTTCCTTCTGGT
ADRβ1 AAGGAACATCAGCAAGCCAC
ADRβ2 TCCACCTGGCTAAGGTTCTG
ADRβ3 CTTCTTTCTGGCCAACGTG
18S
CGCCGCTAGAGGTGAAATTC

Reverse Sequence
GCCCATTAACAGGTCTTCCAAA
TCAGGACACAGTGGCTTTTG
GCCCATTAACAGGTCTTCCA
GAGGCTGCTGTTATCCACAA
AGCACGGATGAATATGTTGC
TGTTGCTTACTGCTGGGATG
GCCCTCGCTTATGATCTGTC
CTACCTCCACCATGCCAAGT
AGTGAGGAACAAGCCAGAGC
CAAGAGCCAGGAAGAAACCA
GGGAGAAAGCTTGTCTCAA
GTGAACTCGAAGCCCACAAT
TGTCCTTCTACGTTCCCCTG
CAGTAGATGAGCGGGTTGAAG
TTGGCAAATGCTTTCGCTC

Immunoblotting
Lysates from cultured cells or tumor were prepared for immunoblotting
using modified RIPA buffer (50mM Tris-hcl [pH 7.4], 150 mM NaCl, 1% Triton,
0.5% deoxycholate) plus 25 µg/ml leupeptin, 10 µg/ml aprotinin, 2mM EDTA, and
1mM sodium orthovanadate. The concentration of protein samples was
determined using a BCA Protein Assay Reagent kit (Pierce Biotechnology,
Rockford, IL). Lysates were loaded and separated on 8%-15% sodium dodecylsulfate-polyacrylamide gels, respective to the protein of interest size. Proteins
were transferred to a nitrocellulose membrane by semidry electrophoresis (BioRad Laboratories, Hercules, CA) overnight, blocked with 5% Bovine Serum
Albumin for 1 hour and then incubated at 4°C with primary antibody overnight.
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TBST was used to wash the membrane thoroughly before incubation with
horseradish

peroxidase

(HRP)-conjugated

secondary

IgG

(1:2000,

GE

Healthcare, UK) for 1 hour. An enhanced chemiluminescence detection kit
(Pierce) was used to visualize HRP. To confirm equal loading of samples, the
blots were probed for an antibody specific to beta-Actin (0.1 µg/ml; Sigma).
ImageJ densitometry analysis was used for quantification.

Migration and Invasion assays
Both assays use a 24-well insert with 8uM pore size and polycarbonate
membrane modified Boyden chamber (Coster, Boston, MA). For migration
assays, the membrane was coated with 0.1% gelatin and an extracellular matrix
component mixture composed of human laminin, type IV collagen and gelatin for
invasion. Single-cell suspension of 75-100,000 tumor cells was seeded into the
inserts in serum free media with serum containing media in the lower chamber to
allow migration and invasion. Cells were incubated at 37°C in 5% CO2 for 8
hours for migration and 24 hours for invasion. The membranes were fixed and
stained at their respective time points, and counted in 5 random fields using light
microscopy at 200x for quantification.

ELISA
Cell lysates were prepared as previously described in methods for
immunoblotting. For both HPV16 E7 ELISA kit (MyBioSource, San Diego, CA)
and cAMP assay kit (Cell Signaling, Danvers, MA), protein was used at the
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concentration of 100µg and compared to standards provided in the kits. In
addition, conditioned media was collected from cells then centrifuged at 4°C,
1200 RPM for 10 min. 100 µl of serum (methods for serum collection described in
methods for tissue processing) or conditioned media were used for measurement
of E7.

Cell Viability Assay
Cells were plated (1x 104 in 100µl) in a 96-well plate. 24-72 hours later, 3(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide or MTT, was added to
each well. Plate was incubated for 2 hours and then absorbance was read at 570
nm (Ceres UV 900C; Bio-Tek Instrument Inc, Winooski, VT).

Anoikis assay
Cells (5 x105 per well) were cultured on low attachment tissue culture
plates for 24-96 hours at 37°C in 5%CO2. After incubation, the cells in
suspension were harvested and centrifuged at 1200 RPM for 5 min. Pellets were
washed with cold PBS supplemented with 0.01% FBS twice. 5nM of SYTOX Red
dead cell stain (Life Technologies, Grand Island, NY) was added to the cells in
PBS/FBS solution, this suspension was then immediately analyzed by flow
cytometry for viability (Gallios Cell Analyzer).
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Proliferation assay
Cells were plated and treated with either siRNA or cultured in conditioned
media for the duration of the experiment. At the respective time point, cells were
incubated with EdU (5-ethynyl-2´-deoxyuridine) at a dilution of 1:100 for 2 hours
before analysis by flow cytometry (Gallios Cell Analyzer). Using the Click-iT EdU
Flow Cytometry Cell Proliferation Assay Kit (Life Technologies, Grand Island,
NY), the EdU incorporation was determined.

Exosome isolation
Cells were treated and maintained in their normal media throughout all
experiments, 24 hours prior to exosomal isolation their media was switched to
media supplemented with Exosome-depleted FBS (System Biosciences,
Mountain View, CA). Cultured media was collected and centrifuged at 4°C, 2000
x g for 30 minutes. The supernatant was removed carefully from pellet and debris
at the bottom of the tube. Total Exosome Isolation Reagent (from cell culture
media) (Invitrogen, Carlsbad, CA) was added 1:2; this suspension was placed on
a rocker at 4°C overnight. Following incubation, samples were centrifuged at
10,000 x g for 1 hour at 4°C. The exosomes, in the pellet, were suspended in
1xPBS or Exosome Resuspension Buffer (Invitrogen, Carlsbad, CA) and used
immediately or stored for further downstream analysis.
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Labeling of exosomes
Exosomes were isolated as described in methods for Exosome isolation
and resuspended in 100µl of PBS. 1µl of Bodipy-TR ceramide (Invitrogen,
Carlsbad, CA) was added to exosome sample for 20 min at 37°C, protected from
light. Excess unincorporated dye was removed following the standard protocol for
the Exosome Spin Columns (Invitrogen, Carlsbad, CA). In short, column is
rehydrated with PBS and exosome sample is applied directly to the center of the
top of the column. After centrifugation, the elution in the bottom will contain just
the labeled exosomes. Exosome tracing experiments were carried out
immediately, excitation efficiency was analyzed for this dye at 594nm
(LSRFortessa X-20 Cell Analyzer).

HPV E7 detection by flow cytometry
Cells were suspended in fixative solution (eBioscience, San Diego, CA) for
1h, RT, in the dark. 1x permeabilization washing buffer (eBioscience, San Diego,
CA) was used to wash cells two times. Cells were stained with primary antibody
(HPV16 E7 and HPV18 E7 1:200, Santa Cruz Biotechnology, Dallas, TX) in 100
µl permeabilization buffer for 30 min on ice. Cells were washed once with
permeabilization buffer before secondary (Alexa-488 conjugated anti-goat for
HPV16 E7 or anti-mouse for HPV18 E7, 1:800) was added. After 30 min in
secondary on ice, suspension was washed once with FACS buffer (2% FBS in
PBS). Flow analysis (LSRFortessa X-20 Cell Analyzer) was performed in 250µl
of FACS buffer.
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Conditioned media experiments
To prepare cultured media, cells (cancer cells, NOF, or conditionedfibroblast) were incubated with minimal amount necessary, in their respective
media supplemented with exosome-free FBS, for 24 hours at 37°. Conditioned
media for NE-treated cells was collected in the same way, treatment with NE was
10µM at the beginning of the 24 our incubation period. Media was removed and
centrifuged at 1200 RPM, 4°C, for 10 min to remove debris. Media was aliquoted
to be stored at -20°C until use or directly placed onto the specific cell type to be
conditioned. When placed in culture to condition, cells were incubated for 2.5
days before media was removed and replaced with a fresh aliquot of conditioned
media or further analysis was performed at this point.

Statistical analysis
Microsoft Excel or GraphPad Prism (Microsoft, Redmond, WA) was used
to analyze data. Continuous variables were compared using the Student t test or
analysis of variance, and the Mann-Whitney test was used to compare
differences. Using 2-way analysis of variance, we determined that a sample size
of 10 animals per group would provide an effective size of 1.3 with 80% power at
a significance level of P = 0.05. We considered P < 0.05 to be statistically
significant. All statistical analyses were expressed as mean ± standard error of
the mean. Kaplan-Meier analysis was used for survival analysis.
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Results
ADRβ expression correlates with cervical cancer patient outcome
In light of previous studies showing the significance of adrenergic
signaling in cancer progression, we chose to assess if ADRβ expression was
correlated with patient survival. Among 166 tumor samples evaluated, 85% had
high ADRβ1 and 61% had high ADRβ2 expression. Patients with high ADRβ2
expression had decreased overall survival (p=0.38, Figure 4).

Biological effect of chronic stress on cervical cancer growth and progression
using orthotopic mouse models
To evaluate the role of stress in cervical cancer progression, we first
established an orthotopic model of cervical cancer since there was no model
where cells are directly injected into the cervix. First, we injected the cell lines
SiHa, CaSki, ME-180, and C4-1 to evaluate their tumorigenicity (Figure 5). The
route of injection we used was laparotomy in which cells are directly injected onto
the cervix at the cervical-uterine junction. We observed tumors in SiHa, ME180,
and C4-1 models. The cervical cancer tumor from an animal injected with SiHa
cells was removed and recycled to create a cell line with high tumorigenicity and
these were used in future in vivo experiments. Tumor growth was monitored
weekly by IVIS imaging for the duration of the experiment. Bioluminescence
imaging showed tumor localization at the cervix within the pelvic region (Figure
5). Further examination of tumor showed lympho-vascular invasion and spread
into the parametrium and pelvic wall (Figure 5).
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Figure 4. ADRβ expression and overall survival in cervical cancer patient
tumors. ADRβ1 and ADRβ2 expression in cervical cancer tumor samples.
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Figure 5. Establishment of an orthotopic model of cervical cancer.
Summary of cervical cancer cells tumorigenicity. Representative images of tumor
growth over 5 weeks monitored by IVIS imaging, and established tumor in the
animals at necropsy.
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This model closely resembles the disease in the clinic and was adapted by our
lab for further studies of studying cervical cancer progression.
To study the biological consequence of chronic stress on cervical cancer
progression, we used a well-characterized restraint stress model and a nonspecific β-blocker, propranolol. Animals submitted to daily restraint stress, had
increased tumor weight and number of nodules while propranolol completely
abrogated this effect (p<0.01 and p<0.05, Figure 6).
We investigated whether the HPV oncogene protein levels could be
modulated by chronic stress in our orthotopic model of cervical cancer.
Interestingly, we observed a trend for elevated E7 protein in tumors from mice
exposed to daily restraint stress compared to controls (Figure 7a). Serum from
tumor bearing mice was also evaluated for E7 protein, showing elevated E7
protein in restraint stress animals (124 vs. 177 ng/µl, Figure 7b). Further
examination of the relative HPV E6/E7 DNA levels in the serum showed elevated
levels in restraint stress animals (Figure 8). To dissect the effect of HPV E6 and
E7 in our in vivo models, we silenced their expression by using DOPC
nanoparticles. Daily restraint stress lead to increased tumor growth and nodules,
while use of HPV16 E6/E7 DOPC siRNA nanoparticles completely blocked this
effect (p<0.0001 and p<0.001, Figure 9). In addition, HPV16 E6/E7 siRNA-DOPC
blocked restraint stress-induced increases in E7 protein in serum, shown by
ELISA (p<0.0001, Figure 10).
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Figure 6. Effect of restraint stress on cervical cancer growth. Total tumor
weight and number of nodules are shown in the SiHa cervical cancer restraint
stress model following treatment with propranolol. **indicates p<0.01, *indicates
p<0.05. (n= 10 animals per group)
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Figure 7. E7 protein expression in tumor and serum samples from restraint
stress in vivo. E7 protein was measured by ELISA. Graphs represent E7 protein
per 100µg of protein lysate (A), or 100µl of serum (B). (n= 3 animals per group)

Figure 8. HPV16 E6/E7 DNA expression in serum from cervical cancerbearing mice. DNA was isolated from 25µl of serum, relative E6/E7 DNA
expression is shown above. (n= 3 animals per group)
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Figure 9. Effect of HPV16 E6/E7 siRNA in restraint stress model of cervical
cancer. Total tumor weight and number of nodules are shown in SiHa cervical
cancer model following treatment with E6/E7 siRNA-DOPC. ****indicates
p<0.0001, ***indicates p<0.001. (n= 10 animals per group)
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Figure 10. E7 protein expression in serum samples from cervical cancer
restraint stress in vivo with HPV16 E6/E7 siRNA. E7 protein was measure by
ELISA. Graph represents E7 protein per 40µl of serum. ****indicates p<0.0001.
(n= 5 animals per group)
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The functional consequences of catecholamine-mediated increases in HPV
oncogenes E6 and E7 in cervical cancer cells
To determine the mechanism and cellular consequences of stress
hormones in cervical cancer cells we first looked at ADRβ expression in a panel
of cell lines by RT-PCR. CaSki, SiHa, ME-180, and C4-1 show expression of β1,
β2, and β3 receptors (Figure 11a). C33A cervical cancer cells are null for all
three of these receptors; therefore we introduced a β2 construct for future
experiments requiring an HPV negative cell line to study the effect of stress
hormones (Figure 11b). To determine if these cells could respond to adrenergic
activation, we measured cAMP levels after exposure to NE or a non-specific βreceptor agonist, isoproterenol (ISO), for 30 min. A significant increase in cAMP
levels was observed in NE and ISO treated ADRβ-positive cells CaSki and SiHa
(p<0.05, Figure 12).
Our in vivo model shows HPV E6 and E7 protein levels were elevated in
daily restraint stress animals tumor and serum, therefore we sought to
investigate the underlying mechanism driving this increase. We first examined if
catecholamines increased E6/E7 mRNA expression in CaSki, SiHa, and ME-180
cells. The quantitative PCR data shows NE or ISO exposure leads to increases
in E6/E7 mRNA by three fold in CaSki (p<0.001, Figure 13). SiHa and ME-180
show similar increases in mRNA at 12 hours post-treatment with catecholamines
(p<0.001 and p<0.01, Figure 13).
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Figure 11. ADRβ expression in a panel of cervical cancer cell lines. ADRβ1,
ADRβ2, and ADRβ3 expression were analyzed by qRT-PCR in CaSki, SiHa, ME180, and C4-1 (A), C33A and C33A-B2 construct (B). Skov3 is an ovarian cancer
cell line, used here as a positive control.
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Figure 12. Intracellular cAMP levels after adrenergic stimulation. Cervical
cancer cells were exposed to NE or ISO and intracellular cAMP levels were
measure by ELISA. *indicates p<0.05.
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Figure 13. Relative HPV oncogene mRNA expression after catecholamine
exposure. Following treatment with NE or ISO, cervical cancer cells relative
mRNA expression for HPV16 E6/E7 (CaSki and SiHa), and HPV18 E7 (ME-180)
were analyzed by qRT-PCR.****indicates p<0.0001, ***indicates p<0.001,
**indicates p<0.01, *indicates p<0.05.
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Since HPV was detected in the serum from tumor-bearing mice, we
analyzed the corresponding supernatant from these treated cells for E7 protein
by ELISA. There was an increase in E7 after 6 hours with NE or ISO (Figure 14).
Next, we analyzed viral DNA isolated from the supernatant samples. qRT-PCR
analyses show 9-fold increases in E6/E7 DNA in the supernatant from samples 3
hours post-treatment with NE and ISO (Figure 15). This data provides evidence
that catecholamines can increase the production and secretion of HPV E6 and
E7.
To examine the cellular response and consequences of stress hormones
in cervical cancer cells we first investigated invasion and migration of cervical
cancer cells treated with NE compared to control. SiHa and ME-180 cervical
cancer cells were treated with NE, and allowed to invade or migrate through a
defined matrix or gelatin coated membrane for 6 hours or 24 hours, respectively.
NE increased cervical cancer invasion (SiHa 127 vs. 156 cells per HPF, p=0.01
and ME-180 97 vs. 138 cells per HPF, p=0.03, Figure 16a, b) and migration
(SiHa 25 vs.42 cells per HPF, p=0.03, Figure 17). To investigate if HPV E6/E7
aids cervical cancer invasion, we treated cells with E6/E7 siRNA prior to the
assay. Transfection with siRNA did not lead to changes in cell proliferation or
viability (data not shown). Cells treated with siRNA showed reduction in invasion
when compared to control (p<0.0001, Figure 18). Further, while NE increased
tumor cell invasion, E6/E7 siRNA completely abrogated this effect (p<0.05 and
p<0.0001, respectively, in Figure 18).
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Figure 14. HPV16 E7 protein expression in supernatant from SiHa cells
exposed to catecholamines. Following treatment with NE or ISO cervical
cancer cells E7 protein expression was measured by ELISA in supernatant.
**indicates p<0.01.
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Figure 15. HPV16 E6/E7 DNA expression in supernatant from SiHa cells
exposed to catecholamines. DNA was isolated from supernatant, relative
E6/E7

DNA

expression

is

shown

above.

****indicates

p<0.0001,

**indicates<0.01, *indicates p<0.05.
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A)

B)

Figure 16. Invasion of cervical cancer cells treated with NE. Cervical cancer
cells were treated with NE and then plated into modified Boyden chambers to
assess invasion (24 hours). Cell numbers per high power field (HPF, 200X) were
then counted. *indicates p<0.05.
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Figure 17. Migration of cervical cancer cells treated with NE. Cervical cancer
cells were treated with NE and then plated into modified Boyden chambers to
assess migration (6 hours). Cell numbers per high power field (HPF, 200X) were
then counted. *indicates p<0.05.
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Figure 18. Invasion of cervical cancer cells with E6/E7 siRNA. Cervical
cancer cells were treated with HPV16 E6/E7 siRNA 36 hours prior to treatment
with NE and plated into modified Boyden chambers to assess invasion (24
hours). Cell numbers per high power field (HPF, 200X) were then counted.
****indicates p<0.0001, *indicates p<0.05.
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To further elucidate the mechanism by which the stress-induced increases
in HPV oncogenes can promote cervical cancer growth and metastasis we
examined their role in anoikis. Anoikis is a process by which cells enter apoptosis
when detached from the extracellular matrix and neighboring cells. We assessed
ME-180 cancer cells maintained in low attachment tissue culture plates for basal
anoikis rates every 24 hours; cells were analyzed by flow cytometry for SYTOX
Red dead cell stain to determine viability. After 48 hours in these conditions, 50%
of the cells went through anoikis and at 72 hours 75% went through anoikis
(Figure 19). Exposure to NE resulted in significant inhibition of anoikis in ME-180
cells (p<0.0001, Figure 20).

The role of exosomal HPV oncogenes in cell-to-cell communication in the tumor
microenvironment
We sought to investigate the biological significance of secreted HPV.
Specifically, we wanted to know if cancer cells and the extracellular HPV can
condition their microenvironment into one that is more supportive for tumor
growth. In this case, we looked at fibroblasts because they have been shown to
be modulated directly by cancer cells [50]. Normal fibroblast cell lines 151 (NOF)
were exposed to supernatant from C33A or SiHa for two days. In the study done
by, Hanahan et. al, genes such as CXCL2, VEGF, IL-6 and IL-8 were said to be
part of the pro-inflammatory gene signature observed in cancer-associated
fibroblast [63]. In our experiment, NOF showed an up-regulated cancer
associated pro-inflammatory gene signature within two days of culture with SiHa
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Figure 19. Basal anoikis rates of ME-180 over 72 hours. Percent of cells
stained as positive for SYTOX Red are graphed here as percent anoikis over
72h.
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Figure 20. NE-induced resistance to anoikis. Cells treated daily with NE are
represented here, compared to control. Percent of cells stained positive for
SYTOX Red are graphed here as percent anoikis. ****indicates p<0.0001.
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(HPV+) conditioned media when compared to C33A (HPV-) conditioned media
(Figure 21a). Furthermore this effect was amplified when fibroblast were exposed
to media from cells treated with NE (Figure 21b). Since we previously showed
HPV in the supernatant, we wanted to see if the NOF became HPV positive after
incubation with the cultured media from SiHa cells. Fibroblasts that were cultured
with conditioned media from SiHa for two days had detectable HPV E6/E7 mRNA
after just 24 hours (p< 0.0001, Figure 22). Proliferation of fibroblast has been
shown to increase when co-cultured with breast cancer cells [64]. To assess if
there was a functional consequence of the CAF conversion by cervical cancer
cells, we analyzed proliferation of the fibroblast conditioned with SiHa cultured
media, with or without NE. There was an increase in fibroblast proliferation, seen
by percent of EdU incorporation after 2 days of co-culture (Figure 23). Since this
was not a robust biological effect, we looked into other functional read outs,
which could be the main driver in how NOF to CAF conversion can promote
progression of cervical cancer.
A change in migration of fibroblasts is a signature characteristic of
transition from normal to a cancer-associated phenotype. To assay the ability of
fibroblast to migrate following exposure to conditioned media, fibroblasts were
cultured for five days and then were plated into gelatin coated modified Boyden
chambers for 8 hours. As expected, NOF fibroblasts cultured with conditioned
media from SiHa cervical cancer cells had increased migration, this effect was
amplified with conditioned media from cervical cancer cells treated with NE (24
vs. 93 and 24 vs. 164, p<0.01 and p<0.001, Figure 24).
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A)

B)

Figure 21. Pro-inflammatory genes expression in fibroblast conditioned
with cervical cancer cell supernatant. mRNA expression changes were
analyzed by qRT-PCR in fibroblast cultured with SiHa and C33A conditioned
media over 2 days. *indicates p<0.05.

	
  

44	
  

Figure 22. HPV mRNA expression in fibroblast conditioned with SiHa cell
supernatant. Analysis of HPV16 E6/E7 mRNA expression by qRT-PCR in
fibroblast after culture with supernatant from SiHa cells.****indicates p<0.0001.
*indicates p<0.05.
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Figure 23. Effect of SiHa cell conditioned media on fibroblast proliferation.
Proliferation graphed as percent of EdU incorporation in fibroblast over 2 hours,
48 hours after placed in SiHa cultured media.**indicates p<0.01.*indicates
p<0.05
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Figure 24. Migration assay for fibroblast with conditioned media from SiHa
cervical cancer cells. Fibroblasts were plated into modified Boyden chambers
to assess migration (8 hours) to conditioned media from cervical cancer cells.
Cell numbers per high power field (HPF, 200X) were then counted. ***indicates
p<0.001. **indicates p<0.01.
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It has been suggested that HPV can only infect stratified epithelium.
Based on our previous finding that HPV E6/E7 mRNA was detectable in NOF
cultured with supernatant from SiHa cells, we wanted to determine how the virus
can infect other cell types. Therefore we hypothesize that HPV viruses can be
packaged into exosomes and transferred to nearby fibroblasts. First, we isolated
exosomes from cervical cancer cells and validated the extraction by determining
the presence of hsc70 on these samples (Figure 25).
The interaction of the cancer cells and the stromal populations, as well as
the ability to penetrate and breakdown the basement membrane represent critical
steps in the metastatic process [65]. To see if the exosomes themselves were
capable of invading a defined matrix that mimics the basement membrane,
exosomes labeled with a red fluorescent dye, Bodipy-TR ceramide, were placed
in an insert coated with defined matrix and allowed to invade for 24 hours.
Fluorescence imaging shows that exosomes were able to penetrate through the
matrix and further they can be visualized amongst cancer cells that were plated
below the insert (Figure 26).
To delineate a mechanism by which normal fibroblasts acquire viral
oncogene expression, we specifically looked at the ability of normal fibroblast to
uptake cervical cancer derived exosomes. Fibroblasts were incubated with
Bodipy-TR ceramide labeled exosomes for 24 hours and analyzed by flow
cytometry. These analyses demonstrate that fibroblast can uptake labeled
exosomes (Figure 27).
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Figure 25. Hsc70 expression by western blot in exosomes isolated from
cervical cancer cells. Exosomes were isolated from cervical cancer cells and
expression was confirmed by western blot.
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Figure 26. Invasion of cervical cancer cell derived exosomes. Labeled
exosomes were plated into modified Boyden chambers to assess invasion (24
hours). Ability to penetrate the matrix was determined by Bodipy-TR ceramide
signal seen in cancer cells plated below the inserts.

	
  

50	
  

Figure 27. Uptake of cervical cancer cell exosomes by fibroblasts. Flow
cytometry results are shown above, the mCherryA positive population represents
the fibroblasts that have taken up Bodipy-TR ceramide labeled cervical cancer
exosomes.
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Since endocytosis is energy dependent process, cells put at 4°C show the
uptake of exosomes is compromised and it completely abrogated this process.
Moreover, to determine if exosomes were a key carrier of HPV viruses, we
incubated fibroblasts with Bodipy-TR ceramide labeled exosomes from SiHa and
ME-180 cervical cancer cells for 24 hours. We detected Alexa-488 conjugated
HPV E7 and the Bodipy-TR ceramide label in fibroblast by flow cytometry. Our
data showed that fibroblasts can uptake exosomes containing HPV E7 proteins
(Figure 28).
NOF treated with cervical cancer supernatant showed enhanced migration
and an increase in some pro-inflammatory genes, which are both supportive of
these cells differentiating into CAFs. SiHa cells conditioned with these converted
fibroblast cultured media resulted in significantly increased invasion when
compared to cells treated with conditioned media from NOF (60 vs. 111,
p<0.0001, Figure 29).
To study if intervention with siRNA for specific genes involved in
exosomes release pathways will abrogate the effects we have seen, we first
silenced the gene SMPD2 in cervical cancer cells. Three sequences were used
to validate knock down of the SMPD2 mRNA in SiHa cells (Figure. 30). All three
of the sequences show a 90% knockdown of SMPD2 mRNA. Future analysis of
supernatant from SMPD2 siRNA treated cells for E7 protein compared to control
is necessary. This data can provide evidence that HPV uses exosomal pathways
for oncoprotein release.
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Figure 28. Detection of exosomal HPV E7 protein in fibroblasts. Flow
cytometry results are shown here. The double positive population in the Q2
quadrant represents the fibroblasts that have taken up the Bodipy-TR ceramide
positive exosomes and E7 protein (HPV E7 specific antibodies were conjugated
to Alexa 488 fluorescent secondary antibody for detection by flow).
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Figure 29. Invasion of cancer cells co-cultured with HPV-CAFs. Normal
fibroblasts were cultured with SiHa conditioned media. HPV positive fibroblasts
were co-cultured with SiHa cells for 24 hours prior to plating them into modified
Boyden chambers for invasion assay (24 hours). Cell numbers per high power
field (HPF, 200X) were then counted. ****indicates p<0.0001.
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Figure 30. SMPD2 siRNA in cervical cancer cells. Three sequences were
used to validate siRNA efficiency specific for the SMPD2 gene in cervical cancer
cells.
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Discussion
Biological significance of stress in cervical cancer progression
While chronic stress has been previously implicated in the progression of
many cancers, the biological significance in cervical cancer had not been
explored. In our detailed investigation of how chronic stress contributes to
cervical cancer progression, we first show daily restraint stress led to increases
in tumor weight and number of nodules in an orthotopic murine model of cervical
cancer. The use of a non-specific beta-blocker, propranolol, completely
abrogated this effect. This finding is suggestive that there is a link between
sustained adrenergic signaling and cervical cancer progression. We provide
evidence that HPV oncogene transcription and translation increases after
catecholamine exposure. This is the first time HPV has directly been shown to
respond to adrenergic signaling. The relationship between catecholamines and
increased HPV is important, as HPV is the primary cause of cervical cancer and
is capable of manipulating numerous pathways in cancer cells [66]. The
significance of HPV oncogenes in a chronic stress model is most dramatically
illustrated by the complete abrogation of tumor growth and number of tumor
nodules when E6/E7 siRNA was used.
In the current study, HPV protein was elevated in tumors and serum from
restraint stress animals when compared to control. This data shows
catecholamines can increase the secretion of HPV in addition to enhancing its
transcriptional activity in cancer cells. Although HPV has been detected outside
of the cell [67], the mechanism by which the virus is maintained extracellularly is
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not understood. We demonstrate, for the first time, cervical cancer derived
exosomes contain HPV oncoproteins. Perhaps the mechanism the virus uses to
maintain latent and persistent infection in an individual is through packaging itself
in cancer cell derived exosomes. Further we show that the HPV containing
exosomes directly interact with fibroblasts, suggesting a novel mechanism HPV
uses for infecting non-epithelial cell populations in the tumor microenvironment.
Our study provides new directions for defining precise mechanisms by which
HPV plays a role in cervical cancer tumor progression.

Mechanisms
To our knowledge, this is the first time neuroendocrine modulation of HPV
via SNS has been demonstrated. In this study, we prove NE-induced increases
in E6/E7 are required for cervical cancer cell invasion. Additionally, cervical
cancer cells expressing E6/E7 show an increased resistance to anoikis when
treated with NE. Together these results demonstrate the consequences of
catecholamine-mediated increases in HPV oncogenes.
The unique and heterogeneous expression of β-receptors in these cervical
cancer cell lines makes delineating one overarching mechanism and pathway
driving increases in HPV oncogenes intricate. To study this mechanism, siRNA
targeting specific ADRβs will be most definitive in identifying the signaling
pathway driving these increases. More evidence is needed to support both
ADRβ-dependent and HPV-dependent processes and their interplay. We did not
address this issue specifically, however a model with HPV negative cells that
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have a functional response to adrenergic stimulus could address the
catecholamine-dependent effects of chronic stress on tumor progression. When
stable expression of HPV is added into this specific model and compared, we
hypothesize the stress effect will be amplified.
While many studies have focused on the effect of HPV in tumor cells and
how the virus function plays a role in oncogenesis [68], we provide a role of the
virus in conditioning the microenvironment and how it may support progression of
cervical cancer. The exosomes from cervical cancer cells were shown to contain
the oncogene E7, supporting a route by which cancer cells are directly
modulating their environment via oncogene transfer. After determining the ability
of exosomes to penetrate a basement membrane like setting, we wanted to
examine the capability of these exosomes to be uptake by cells found in the
microenvironment such as; immune cells, macrophages, endothelial cells, or
fibroblast. The data presented here shows fibroblasts can uptake cervical cancer
cell derived-exosomes.

Another avenue we can explore to determine the

significance of the exosomes is their role in vivo in tumor progression by using
CD63-GFP labeled cancer cells. Analysis of these tumors and the surrounding
tissue can help us understand the extent to which the exosomes are released in
vivo and where they are primarily taken up or located. Furthermore, we can
explore the effect of the exosomes on the other cell types in the
microenvironment that we did not elucidate on here.
Several other experiments are necessary to dissect specifically what the
exosomes alone are contributing to the fibroblast. Experiments addressing the

	
  

58	
  

cervical cancer cell derived exosomes are critical so we can know more about
their content, release, and uptake. The exosomal release mechanisms are of
primary interest because interfering with these pathways can abolish the
communication and delivery of these oncogenes from the tumor in the first place.
To block exosomal release, inhibitors or siRNA for Rab family members (Rab11,
Rab27, Rab35), SMPD2 shRNA, or inhibitors of the endosomal sorting
complexes required for transport (ESCRT) machinery can be used [55].
Experiments using these types of inhibitors will definitively support if the
exosomes are the component in the cervical cancer cultured media that are
responsible for altering the fibroblast by transferring HPV oncogenes to them.
Furthermore, the inhibitors that show most efficacies in vitro can be formulated
for application in an in vivo setting. Studies addressing exosomal release and
developing ways to disrupt these pathways could provide beneficial therapeutic
targets, which could be used in adjuvant to current treatment options.
The ability of cancer cells to modulate fibroblast, and become CAFs, has
been recently established for breast, ovarian, and prostate cancers [64]. We are
currently showing the fibroblast conditioned by cervical cancer cells have
increased

migration,

proliferation,

and

increased

pro-inflammatory

gene

expression. Furthermore we support a paracrine feedback on the cancer cells
from the reprogrammed fibroblasts, which caused an increase in cancer cell
invasion. It is possible that exosomes released from the conditioned vs. normal
fibroblast are different in content and concentration which can directly be
affecting the cancer cells. The communication between the cancer cells and
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fibroblasts is demonstrated here as a potential explanation for priming the tumor
microenvironment. The mechanism underlying the communication from the CAFs
to cervical cancer cells which leads to increased invasion needs to be dissected.
This study provides a mechanism by which cell-to-cell communication is
promoting cervical cancer progression via a positive feedback loop.
To determine if HPV is required in the CAF-like transformation of normal
fibroblast, the role of HPV in the fibroblast needs to be examined. Based on our
evidence, we show a novel mechanism for viral packaging and infection via
exosomes to the fibroblasts. The specific interactions E6 and E7 proteins have in
the fibroblast are unidentified to this point and a mass spectrometry analysis of
this would be of interest. To address the transforming capabilities of HPV
oncogenes in the fibroblasts, a stable expression of HPV E6/E7 in fibroblasts is
necessary.

Clinical implications
We demonstrate a reliable animal model for studying the progression of
cervical cancer. Our orthotopic model of cervical cancer closely resembles the
tumor growth and spread that is seen in the clinic. This model has excellent
efficiency and gives researchers the ability to accurately predict clinical
outcomes.
Our study has important clinical significance. We show the significant
reductions in tumor burden with the use of propranolol in cervical cancer. This is
an extremely important foundation to support using β-blockers in clinic in
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combination with other therapies for cervical cancer, to prolong survival and help
make current therapies more effective. ADRβ2 expression was related to overall
survival in cervical cancer patients, which complements why the use of betablockers in this population could be beneficial.
Detection of HPV in patients has recently been used as a diagnostic
marker simultaneously with abnormal cervical cytology, to increase the amount of
screening a patient is advised in the hopes of preventing lesions or detecting
lesions in very early and treatable stages [69]. The relationship between HPV
expression and progression of the disease in patients, such as tumor stage and
grade or overall survival, should be further studied in patients. Also, ISH for HPV
DNA in tumor tissues will further tell us more about the interplay between the
microenvironment and developed tumors. We predict the patients with high-HPV
in the blood will additionally have more invasive tumors, more metastasis, and
poorer overall survival. This data together could be further correlated with
depression or stress assessments to support a clinical relationship between
psychosocial distress and cervical cancer progression.
Exosomes are currently of interest in the nanotech field for therapeutic
potential. Investigation of whether or not E6/E7 silencing will minimize the
progression through less transfer of oncogenes is pending. Further examination
by use of high-throughput platforms such as RPPA or gene array of the cervical
cancer cell derived exosomes will provide more insight into the biogenesis and
content of these vesicles. This disease has a very long time until it presents with
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large and bulky tumor and if we can prevent the virus from potentiating its effects
in progression we eliminate a hurdle current therapies do not address.

Conclusions
Evidence presented offers a new insight into not only stress-related
pathways but also viral oncology and overall tumor biology. We addressed the
three hypotheses of this project. In the current study, we demonstrate a
previously unrecognized role of sustained adrenergic signaling in cervical cancer
tumor progression. We show chronic stress increases HPV oncogene expression
in vivo and in vitro. Catecholamine-driven increases in HPV promote tumor
progression through increased cancer cell invasion and resistance to anoikis in
vitro. Further review of HPV led us to the finding that the virus is secreted and
has an emerging role in manipulating the microenvironment. We offer a complex
but reliable model for explaining the influence of viral transfer through exosomes
to the microenvironment. More importantly, the stromal changes are shown to
play a biologically significant role in promoting cervical cancer cell invasion.
Collectively, these data are translatable findings that need to be further examined
and pursued to uncover the mechanisms behind our research.
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